iiinova — where your digital self keeps evolving

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 29/05/2025

An important message on naltrexone in patients with liver disease: ✅Naltrexone can help reduce alcohol use without harming the liver. 🚫Alcohol DOES harm the liver. We do not need any more barriers to treat patients with AUD➕ALD! @nejm.org @ebtapper.bsky.social www.nejm.org/doi/full/10....

0114

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 06/05/2025

In an epidemic of alcohol-use disorder, alcohol-associated liver disease, and cancers driven partially by 🥂🍸🍺, click-bait headlines like these are extremely harmful for population health. Let’s do better for our patients and public health. @theguardian.com @nytimes.com @cnn.com @washingtonpost.com

010

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 03/05/2025

When did the hotel mini-bar get not-so-mini?! As an alcohol-associated liver disease focused hepatologist, this trend is very concerning!

040

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 18/04/2025

Home *slightly* early on this gorgeous Friday afternoon for some light reading with my 12.3 lb besties on enteral feeding in hospitalized patients. @nejm.org This is the life! @GISky @liversky @medsky

110

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 05/04/2025

“DEI and proud” “Donald Trump’s worst nightmare” Happy to be in NYC and supporting ReelAbilities Comedy Night

000

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 04/04/2025

Naltrexone in 🍷🍸🍺-associated liver disease ✅ Overall, safe for treatment of alcohol use disorder in this population Black box warning for chronic liver disease was REMOVED in 2013: 🚫 evidence of harm 🔑 Alcohol causes harm to the liver, naltrexone does NOT Slides: #ALD-ALLY Lamia Haque #liversky

062

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 27/03/2025

This picture reminds me how I have always been extremely goal oriented (Also: So much fun to share this with my mini-me. Bonus: my dad teaching my son how to aim as well as fly fish in high desert streams!)

030

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 10/03/2025

Really liking this trend of puppies, especially given everything else going on with the world and science. Her is mine when she was a pup! Now is a ~13lbs.

180

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 01/03/2025

Amazing #liversky conference by @aasldnews.bsky.social @juanpabloarab.bsky.social + Mazen Noureddin on alcohol-associated liver disease and MetALD. So many great minds working in this area to improve our patients’ lives. Always 👌 time to be a Hepatologist! @vinayjaha.bsky.social #medsky #academicsky

060

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 28/02/2025

FANTASTIC presentation by phenomenal patient advocate Jennifer Jones. Hearing from patients about their experience moving through our system is 👀. 👏 We need to take every opportunity to diagnose liver disease AND we need to continue to work on stigma: language matters! @juanpabloarab.bsky.social

010

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 25/01/2025

Wonderful to present my project on prevalence of ceruloplasmin in patients with alcohol-use disorder @easlnews.bsky.social #SLDSummit

091

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 25/01/2025

Excellent talk by @luisantoniodiaz.bsky.social on public health policies and MASLD/outcomes 👌 ✅ Policies on healthy eating, diabetes, and cardiovascular disease are associated with improved outcomes and should be prioritized @easlnews.bsky.social #liversky #SLDSummit #PublicHealth #GlobalHealth

083

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 25/01/2025

And some excellent slides from a 👌 Shira Zelber-Saga

010

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 25/01/2025

From Dr Frank Murray: ♦️Alcohol is a major global problem ➡️ years of life lost ♦️⚠️Labels—cancer risk! ♦️Need for public health interventions: 🚫 ads, ⬆️ price, tax, implement POLICIES ♦️Challenges: powerful 🍸 lobbies ✅We need to 📣 for evidence-based policies! @easlnews.bsky.social #liversky #SLDSummit

0102

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 25/01/2025

131

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 25/01/2025

🔹Lots of hormone dysregulation in SLD, especially insulin and glucagon 🔹Gut hormones play important roles (GLP, GIP) 🔹Thyroid hormones are also implicated 🔹Lots of drug targets with an exciting future ahead for patients with MASLD! @easlnews.bsky.social #SLDSummit #liversky

040

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 25/01/2025

🔸Associated with abnormal glucose tolerance/development of DM 🔸These 🧒 need to be followed for progression/development of MASLD 🔸Associated w/ cardiac risks, long term morbidity and mortality 🔸Differences from MASLD in 🧒 vs 🧑 🔸Need prevention, earlier screening, and treatment for peds MASLD

000

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 25/01/2025

🔸MASLD is 📈 in pediatrics 🔸Not all steatosis in 🧒 is MASLD (inborn errors of metabolism) 🔸Gestational DM, PNPLA3, parental obesity ⬆️ risk, w/ PNPLA3 associated w/ advanced fibrosis risk 🔸🚫 fructose🥤 🔸⬆️BMI in 🧒 🔀 cirrhosis/HCC as 🧑 #liversky #pediatricsky #medsky @easlnews.bsky.social #SLDSummit

151

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 25/01/2025

👌 talk on extraheatic complications of MASLD MASLD & metabolic disease are 🔗, w/📈 severity of MASLD correlates w/ severity of metabolic disease & MACE. Both 🔗 & causality: patients w/ MASLD have different phenotypes w/ implications for treatment and personalized medicine #liversky #SLDSummit

151

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 24/01/2025

In other non #liversky #medsky news, my sister’s film (non-profit producer Shine Global) was nominated for an Oscar! It will be coming out on @netflix.com soon! Her production company focuses on issues facing children, with all profits donated to NGOs supporting kids! 👏

360

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 23/01/2025

Excellent talk by THE @majathiele.bsky.social on finding fibrosis in the population. 🔑 Find the patients where they are and use the tests that you have at hand #SLDSummit @easlnews.bsky.social

050

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 22/01/2025

Dear BlueSky: Contemplating a European move (if only)

360

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 03/01/2025

Just another day on inpatient hepatology service with no time for exercise.

070

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 14/12/2024

For my birthday/christmas, I asked my husband for a new monitor. It came. As he was setting it up for me, he realized how bad my old👩‍💻 is (a hand me down from him several years ago, essentially non-functional after the most recent 🍏 update), so bought me a new one! ☺️😍

120

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 10/12/2024

What a wonderful birthday gift: year 12 (⁉️) of celebrating my birthday with widows in south India. We have a project where we employ widows to make low cost sanitary napkins that are then sold/donated to schools. Feeling inspired to donate? Check out our out of date website: www.shelter-int.org

060

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 29/11/2024

Dragged my husband with me (yes, we have matching bikes)

010

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 29/11/2024

Solution: Ride bike to the gym to use steam room 🧖‍♀️

100

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 28/11/2024

This is one of the most exciting abstract acceptances for me as a fellow—heading to EASL ⁦‪SLD conference in Portugal to present my work in AUD/ALD and see all the amazing work being done in this field! #liversky

090

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 24/11/2024

Ran a poll on x with interesting results. I like the idea of a “master” CV w/ everything & getting rid of abstracts once associate level is reached. Reminder to medical trainees to periodically update your CV! (As I update mine w/ abstracts that will stick around a bit longer) #MedEd #liversky

060

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 17/11/2024

We are surrounded by greats in Hepatology. What a privilege to work amongst so many amazing and inspiring people with the goal of improving the lives and livers of our patients. #liversky

050

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 16/11/2024

ALD and MASLD are a lot alike. How do we tell them apart on pathology? Cindy Behling walks us through in this fantastic talk. 👏 #TLM24 #Liversky @juanpabloarab.bsky.social #pathologysky

1146

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 15/11/2024

Walking us through the MASH pipeline with THE Mazen Noureddin at the PG course. As always, it’s an exciting time to be a hepatologist! #TLM24 #liversky @AASLD

0101

Hanna Blaney, MD, MPH @blaneymd.medsky.social · 15/11/2024

Come find me at #TLM24! I will also be at the LFN trainee reception Saturday 7 pm Members lounge room 4–open to all! LFN also has a do not miss “ask me anything” session directly following the career development workshop geared for near-peer mentoring for trainees at all career stages! #liversky

0112